Collagen Type III - Biosynthesis
Research News and Information

Saturday, November 21, 2009

Chronic angiotensin-(1-7) administration improves vascular remodeling after angioplasty through the regulation of the TGF-beta/Smad signaling pathway in rabbits.

24 Aug 2009 OBJECTIVE: Angiotensin-(1-7) [ANG-(1-7)] has been reported to attenuate neointimal formation after vascular injury and stent implantation in rats, but the mechanism remains mostly unresolved. Interestingly, the levels of circulating transforming ... Read more...

Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression.

30 Jul 2009 Platelet-rich plasma (PRP) has generated substantial interest for tendon and ligament regeneration because of the high concentrations of growth factors in platelet alpha-granules. This study compared the temporal release of growth factors from bone ... Read more...

Healing of extraction sockets in collagenase-2 (matrix metalloproteinase-8)-deficient mice.

30 May 2009 Matrix metalloproteinase-8 (MMP-8) participates in skin wound healing and inflammation. We hypothesized that MMP-8 plays a role in wound healing after tooth extraction and in periapical inflammation. Bone formation, collagen metabolism, and ... Read more...

Latest indexed articles for 'Collagen Type III - Biosynthesis'

These are the very latest articles for this heading:

• Chronic angiotensin-(1-7) administration improves vascular remodeling after angioplasty through the regulation of the TGF-beta/Smad signaling pathway in rabbits. 24 Aug 2009
• Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. 30 Jul 2009
• Healing of extraction sockets in collagenase-2 (matrix metalloproteinase-8)-deficient mice. 30 May 2009
• The linker region of Smad2 mediates TGF-beta-dependent ERK2-induced collagen synthesis. 20 May 2009
• Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. 29 Apr 2009
• Differential long-term stimulation of type I versus type III collagen after infrared irradiation. 26 Apr 2009
• Reduced collagen biosynthesis is the hallmark of cerebral aneurysm: contribution of interleukin-1beta and nuclear factor-kappaB. 7 Apr 2009
• Enhancement of fibroblast proliferation, collagen biosynthesis and production of growth factors as a result of combining sodium hyaluronate and aminoacids. 30 Mar 2009
• Intense pulsed light effects on the expression of extracellular matrix proteins and transforming growth factor beta-1 in skin dermal fibroblasts cultured within contracted collagen lattices. 28 Mar 2009
• Pentoxifylline modifies three-dimensional collagen lattice model contraction and expression of collagen types I and III by human fibroblasts derived from post-burn hypertrophic scars and from normal skin. 17 Mar 2009
• Efficient inhibition of fibroblast proliferation and collagen expression by ERK2 siRNAs. 11 Mar 2009
• Chronic administration of ursodeoxycholic acid decreases portal pressure in rats with biliary cirrhosis. 30 Dec 2008
• Distribution of tenascin-C, fibronectin and collagen types III and IV during regeneration of rat submandibular gland. 16 Dec 2008
• Renoprotective effect of azelnidipine in rats. 29 Nov 2008
• Induction of collagen by estradiol: difference between sun-protected and photodamaged human skin in vivo. 30 Aug 2008
• Detection and characterization of chondroid metaplasia in canine atrioventricular valves. Aug 2008
• [Effect of frequency of cyclic tensile strain on extracellular matrix of rat vascular smooth muscle cells in vitro] 30 Jul 2008
• Immunohistochemical analysis of type III collagen expression in the lingual mucosa of rats during organogenesis of the tongue. 25 Jul 2008
• Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. 29 Jun 2008
• Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease. 28 Apr 2008

See a longer list of these articles.

Technical information about 'Collagen Type III'

Definition: A fibrillar collagen consisting of three identical alpha1(III) chains that is widely distributed in many tissues containing COLLAGEN TYPE I. It is particularly abundant in BLOOD VESSELS and may play a role in tissues with elastic characteristics.

Registry Number: 0

Descriptor UI: D024061

Alternative terms: Collagen Type III; Type III Collagen; Collagen, Type III; Collagen Type III, alpha1 Chain; Collagen alpha1(III); Type III Procollagen; Procollagen Type III;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D05.750.078.280.300.300; D12.776.860.300.250.300.300;

History Note: 2002; use COLLAGEN 1990-2001; for PROCOLLAGEN TYPE III use PROCOLLAGEN 1990-2001

Technical Notes: precursors: coord IM with PROCOLLAGEN (IM)